Cellebrite DI Ltd. (NASDAQ:CLBTW) Short Interest Update

Cellebrite DI Ltd. (NASDAQ:CLBTWGet Free Report) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 15,400 shares, a growth of 3,750.0% from the January 15th total of 400 shares. Based on an average trading volume of 24,300 shares, the short-interest ratio is presently 0.6 days.

Cellebrite DI Stock Down 3.6 %

CLBTW opened at $1.59 on Monday. The company has a fifty day moving average price of $1.44 and a two-hundred day moving average price of $1.29. Cellebrite DI has a 52 week low of $0.67 and a 52 week high of $1.90.

Institutional Trading of Cellebrite DI

An institutional investor recently raised its position in Cellebrite DI stock. Crescent Park Management L.P. boosted its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBTWFree Report) by 3.3% in the second quarter, according to its most recent filing with the SEC. The firm owned 549,432 shares of the company’s stock after acquiring an additional 17,545 shares during the period. Cellebrite DI accounts for 0.2% of Crescent Park Management L.P.’s portfolio, making the stock its 27th largest position. Crescent Park Management L.P.’s holdings in Cellebrite DI were worth $681,000 as of its most recent SEC filing.

Cellebrite DI Company Profile

(Get Free Report)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the United States, and the Asia-Pacific. Its DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.

See Also

Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.